Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation

€50,000 award goes to Newcastle University, in collaboration with Medical University, Graz and Newcastle Hospitals NHS Foundation Trust STAINES-UPON-THAMES, England, March 26, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the recipient of 2019’s Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award. The winning entry was submitted by co-investigator Dr. Rachel […]

Read more